Navigation Links
Agnitio Grants 10,000 New Licenses Globally this Financial Year
Date:6/12/2013

COPENHAGEN, Denmark, June 12, 2013 /PRNewswire/ --


  • New licenses in Europe, the Americas and APAC
  • Life science companies able to individualize their interactions with customers

Agnitio, the closed loop marketing specialist for the life sciences industry, has granted 10,000 new licenses within this financial year alone to life science companies across Europe, the Americas and APAC.

     (Logo: http://photos.prnewswire.com/prnh/20120924/562917-a)

     (Photo: http://photos.prnewswire.com/prnh/20130320/601933 )

With competition for the attention of healthcare professionals becoming ever more intense, Agnitio's solution provides its users with the vital benefits of great speed, ease and flexibility. These advantages allow life science companies to truly individualize their interactions with customers, maximizing time and building trusted relationships.

"Life science companies around the world are increasingly embracing our solution and providing 10,000 new licenses this financial year shows the faith major players have in it," says Eyal Steinitz, COO of Agnitio. "The closer you can get to healthcare professionals and provide them with the specific information they want and need, whenever and wherever they need it, the more valuable you become.

"The digital technology is now there to allow this. Sales reps really can drill down and be highly personalized in their interaction with their customers. They're not forced to fit them into any kind of group anymore."

Building on more than a decade's worth of experience, Agnitio is due to launch Rainmaker, a completely new family of products later this year. Leveraging the single Rainmaker system across all affiliates and regions of a company will allow for quick and cost-effective individualized usage of modules, functionalities and channels based on the local needs.

In March this year Agnitio introduced Rainmaker One, a scalable, service based version of Rainmaker that can support a full closed loop marketing roll out.

About Agnitio

Agnitio helps pharmaceutical and medical device companies generate effective relationships with medical professionals through its leading pull marketing software and services. Already implemented in more than 45 countries and 25 languages, it is used by life science companies including: Allergan, AMGEN, Bayer, Grünenthal, Roche, and Takeda.

http://www.agnitio.com

For further information please contact:
Katrine Bach, Agnitio:
Tel +45-40-30-59-95 or +45-70-14-23-69
Email: kb@agnitio.com
or
Julien Cozens, Madano Partnership:
Tel +44(0)7867-998222 or +44(0)207-593-4000
Email: julien.cozens@madano.com


'/>"/>
SOURCE Agnitio
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Agnitio Launches Rainmaker One to Remove the Complexity of Managing Independent Apps
2. Agnitio Sets Up Asia HQ in Shanghai and is the First to Bring the Combined Closed Loops of Marketing and E-Learning to the Pharmaceutical Industry
3. FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer
4. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
5. Cardinal Health Foundation Invites Local Non-profit Organizations To Apply For Grants To Prevent Prescription Drug Abuse
6. FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
7. FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
8. Pancreatic Cancer Action Network Opposes Sequestration Cuts To National Institutes Of Health & Cancer Research Grants
9. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
10. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
11. FDA Grants Orphan Drug Status To Eisais Lenvatinib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):